Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma

20 Apr 2021

Abstract excerpt

BACKGROUND: Lung adenocarcinoma (LUAD) is the leading cause of cancer-related death. This study aimed to develop and validate reliable prognostic biomarkers and signature. METHODS: Differentially expressed genes were identified based on three Gene Expression Omnibus (GEO) datasets. Based on 1052 samples' data from our cohort, GEO and The Cancer Genome Atlas, we explored the relationship of clinicopathological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Endoplasmic Reticulum Stress and Disease
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33879165
DOI: 10.1186/s12935-021-01938-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

NEIL3 may act as a potential prognostic biomarker for lung adenocarcinomaPMID 33879165Read ↗

Construction of NEIL3 as a Prognostic Biomarker and Co-expressed Prognostic Signature in Lung AdenocarcinomaSemantic proximity Read ↗

A Novel Inflammatory-Related Gene Signature Based Model for Risk Stratification and Prognosis Prediction in Lung AdenocarcinomaSemantic proximity Read ↗

Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinomaSemantic proximity Read ↗

Seven-gene biomarkers reveal prognostic and immune signatures in lung adenocarcinomaSemantic proximity Read ↗

Systematic construction and validation of an immune prognostic model for lung adenocarcinomaSemantic proximity Read ↗

Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinomaSemantic proximity Read ↗

Development and validation of an immune‐related prognostic signature in lung adenocarcinomaSemantic proximity Read ↗

Integration of osimertinib-targeted EGFR gene-associated differential gene expression in constructing a prognostic model for lung adenocarcinomaSemantic proximity Read ↗

Identification and validation of immune-related lncRNA prognostic signature for lung cancerSemantic proximity Read ↗

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung AdenocarcinomaSemantic proximity Read ↗

Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosisSemantic proximity Read ↗

HILPDA: A Novel Prognostic Biomarker for Lung Adenocarcinoma Identified by Integrated Bioinformatic Analysis and Experimental ValidationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.